Inverness Counsel’s Repligen RGEN Stock Holding History

Inverness Counsel’s Portfolio RGEN Stock Details RGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-800	Closed	-$231K	–	198
2021 Q3	$231K	Buy	+800	New	+$205K	0.01%	165
2021 Q1	–	Sell	-1,200	Closed	-$230K	–	159
2020 Q4	$230K	Buy	+1,200	New	+$218K	0.01%	135

Other funds holding RGEN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Inverness Counsel's RGEN Position: Q4 2021 in Review

Inverness Counsel sold out of Repligen (RGEN) in Q4 2021, closing a stake of 800 shares — an estimated $231K sold.

Inverness Counsel first reported a position in RGEN in Q4 2020 and held it in 2 quarters. The position peaked at $231K in Q3 2021. 507 funds tracked by Wall St. Rank hold RGEN as of Q4 2021.

Inverness Counsel reported no remaining Repligen position as of Q4 2021 after selling out during the quarter.
Inverness Counsel sold 800 Repligen shares in Q4 2021, an estimated $231K.
Inverness Counsel first reported a position in Repligen in Q4 2020 and held it in 2 quarters.
Inverness Counsel's Repligen position peaked at $231K in Q3 2021.
507 funds tracked by Wall St. Rank held Repligen as of Q4 2021.

Based on Inverness Counsel's 13F filing for Q4 2021, filed 7 Feb 2022.